A Clinical Trial to study the effect of tablet Vyoshadi guggulu along with the Vaitarana Basti protocol in Rheumatoid Arthritis.
- Conditions
- Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified
- Registration Number
- CTRI/2023/06/054110
- Lead Sponsor
- Dr Nagashree
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
American College of Rheumatology/ European League against Rheumatism classification criteria for Rheumatoid Arthritis 2010, Subjects who fulfills a score of greater than or equal to 6/10 with Duration of symptoms greater than or equal to 6 weeks and Lesser than or equal to 10 years.
Subjects,
1.On drug therapy such as DMRADâ??s.
2.With Severe joint deformity.
3.Diagnosed with Spine, Gout, Ankylosing spondylosis, Osteoarthritis, Traumatic arthritis, Psoriatic arthritis, Infective Arthritis, Septic arthritis and Pyogenic Osteomyelitis.
4.With associated co-morbidities such as Cardiac disease, Pulmonary Tuberculosis, Uncontrolled Diabetes Mellitus, Malignant Hypertension, Renal Function Impairment.
5.Pregnant and Lactating Women.
6.Contraindicated for Basthi procedure.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Simple Disease Activity Index (SDAI) of Rheumatoid Arthritis. <br/ ><br>2.Pratyatma Lakshanas Of Amavata. <br/ ><br>Timepoint: Day-0 & Day-32
- Secondary Outcome Measures
Name Time Method QoL- RA (Quality of Life- Rhematoid Arthritis) QuestionnaireTimepoint: Day-0 & Day-32